Evidence map›Paper›PMID 33335166›Full record

ArticleScientific reports2020

Two high-rate pentose-phosphate pathways in cancer cells.

Vanessa Cossu, Marcella Bonanomi, Matteo Bauckneht, Silvia Ravera, Nicole Righi, Alberto Miceli, Silvia Morbelli, Anna Maria Orengo, Patrizia Piccioli, Silvia Bruno and 3 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Dual roles ofFrontiers in immunology · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Vanessa CossuDepartment of Health Sciences, University of Genoa, Via Antonio Pastore 1, 16132, Genoa, Italy. vane.6291@gmail.com.
Marcella BonanomiDepartment of Biotechnology and Biosciences, University of Milano-Bicocca, Piazza della Scienza 2, 20126, Milan, Italy.
Matteo BaucknehtDepartment of Health Sciences, University of Genoa, Via Antonio Pastore 1, 16132, Genoa, Italy.
Silvia RaveraDepartment of Experimental Medicine, University of Genoa, Via de Toni 14, 16132, Genoa, Italy.
Nicole RighiDepartment of Biotechnology and Biosciences, University of Milano-Bicocca, Piazza della Scienza 2, 20126, Milan, Italy.
Alberto MiceliDepartment of Health Sciences, University of Genoa, Via Antonio Pastore 1, 16132, Genoa, Italy.
Silvia MorbelliDepartment of Health Sciences, University of Genoa, Via Antonio Pastore 1, 16132, Genoa, Italy.
Anna Maria OrengoIRCCS Ospedale Policlinico San Martino, UO Nuclear Medicine, Largo Rosanna Benzi 10, 16132, Genoa, Italy.
Patrizia PiccioliCell Biology Unit, IRCCS Ospedale Policlinico San Martino, Largo Rosanna Benzi 10, 16132, Genoa, Italy.
Silvia BrunoDepartment of Experimental Medicine, University of Genoa, Via de Toni 14, 16132, Genoa, Italy.
Daniela GaglioISBE. IT/Centre of Systems Biology, Piazza della Scienza 4, 20126, Milano, Italy.
Gianmario SambucetiDepartment of Health Sciences, University of Genoa, Via Antonio Pastore 1, 16132, Genoa, Italy.
Cecilia MariniIRCCS Ospedale Policlinico San Martino, UO Nuclear Medicine, Largo Rosanna Benzi 10, 16132, Genoa, Italy.
Ospedale Policlinico San Martino · ITUniversity of Genoa · ITUniversity of Milano-Bicocca · ITInstitute of Molecular Bioimaging and Physiology · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The relevant role of pentose phosphate pathway (PPP) in cancer metabolic reprogramming has been usually outlined by studying glucose-6-phosphate dehydrogenase (G6PD). However, recent evidence suggests an unexpected role for a less characterized PPP, triggered by hexose-6-phosphate dehydrogenase (H6PD) within the endoplasmic reticulum (ER). Studying H6PD biological role in breast and lung cancer, here we show that gene silencing of this reticular enzyme decreases cell content of PPP intermediates and D-ribose, to a similar extent as G6PD silencing. Decrease in overall NADPH content and increase in cell oxidative status are also comparable. Finally, either gene silencing impairs at a similar degree cell proliferating activity. This unexpected response occurs despite the absence of any cross-interference between the expression of both G6PD and H6PD. Thus, overall cancer PPP reflects the contribution of two different pathways located in the cytosol and ER, respectively. Disregarding the reticular pathway might hamper our comprehension of PPP role in cancer cell biology.

Indexed as

Energy MetabolismPentose Phosphate PathwayAnimalsChromatography, LiquidEndoplasmic ReticulumGene SilencingGlucosephosphate DehydrogenaseHumansMass SpectrometryMetabolomicsNADPNeoplasmsOxidation-ReductionOxidative StressReactive Oxygen SpeciesGlucosephosphate DehydrogenaseNADPReactive Oxygen Species

Identifiers

PMID33335166
PMCPMC7746718
OpenAlexW3112280404

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.